A

Austin Neuromuscular Center | Austin, TX

Research site
(Unclaimed)
Location
3901 Medical Parkway, Suite 300, Austin, Texas, United States of America

Site insights

Top conditions

Top treatments

BIIB067
SRP-5051
AMX0035
FLX-787
Superoxide
Nipocalimab
Pregabalin
Duloxetine
Mexiletine
Octagam

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

12 of 26 total trials

A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy (ARDA+)

This trial is an extension of the antecedent trial ARGX-117-2002. It is a multicenter trial that has been designed to evaluate the long-term safety a...

Enrolling
Multifocal Motor Neuropathy (MMN)
Biological: ARGX-117
Other: Placebo

This is a phase 2, randomized, double-blinded, placebo-controlled, parallel-group, multicenter trial to evaluate the safety and efficacy of 2 dose re...

Active, not recruiting
Multifocal Motor Neuropathy
Biological: ARGX-117
Other: Placebo

The primary objective of this study is to evaluate the efficacy of tofersen in presymptomatic adult carriers of a superoxide dismutase 1 (SOD1) mutat...

Enrolling
Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation
Drug: Tofersen
Drug: Placebo

The purpose of this study is to measure the long-term safety and tolerability of efgartigimod PH20 SC in adult participants with IIM who previously p...

Enrolling
Dermatomyositis
Myositis
Biological: EFG PH20 SC

A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Efficacy and Safety of ABC008 in the Treatment of Sub...

Active, not recruiting
Inclusion Body Myositis
Drug: ABC008

The primary objective is:To evaluate the effect of pozelimab + cemdisiran on daily functioning that is impacted by signs and symptoms in patients wit...

Enrolling
Generalized Myasthenia Gravis
Drug: Pozelimab
Drug: Pozelimab + Cemdisiran

This study's purpose is to measure the treatment response from efgartigimod PH20 SC compared with placebo in participants with Idiopathic Inflammator...

Enrolling
Dermatomyositis
Myositis
Other: PBO
Biological: EFG PH20 SC
Locations recently updated

The main purpose of this study is to evaluate the safety and efficacy of nipocalimab compared to placebo in delaying relapse in adults with chronic i...

Enrolling
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Drug: Nipocalimab
Drug: Placebo

A study of sevasemten (EDG-5506) in Becker muscular dystrophy (known as CANYON) and pivotal cohort (known as GRAND CANYON). The EDG-5506-201 CANYON s...

Enrolling
Becker Muscular Dystrophy
Drug: Placebo
Drug: Sevasemten 10 mg

The Phoenix Trial is a randomized double blind placebo controlled Phase III trial to evaluate the safety and efficacy of AMX0035 for treatment of ALS

Active, not recruiting
Amyotrophic Lateral Sclerosis
Drug: AMX0035
Other: Placebo

The purpose of this study is to evaluate the efficacy and safety of orally administered M5049 in idiopathic inflammatory myopathies, specifically der...

Enrolling
Dermatomyositis
Polymyositis
Drug: Placebo
Drug: M5049 high dose

This study will be comprised of 2 parts: 1) Part A (Multiple Ascending Dose \[MAD\]) will be conducted to evaluate the safety and tolerability of ves...

Active, not recruiting
Duchenne Muscular Dystrophy
Drug: Vesleteplirsen

Trial sponsors

argenx logo
H
University of Kansas logo
A
Alexion Pharmaceuticals logo
A
A
Baxalta logo
Biogen logo
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems